| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 3 | Q3 2023 | 88.9% |
| NU HLDGS LTD | 3 | Q3 2023 | 17.3% |
| ISHARES TR | 1 | Q4 2022 | 83.9% |
| NU HLDGS LTD | 1 | Q4 2022 | 16.1% |
| MADRIGAL PHARMACEUTICALS INC | 1 | Q3 2023 | 6.7% |
| AKERO THERAPEUTICS INC | 1 | Q3 2023 | 6.0% |
| 89BIO INC | 1 | Q3 2023 | 2.2% |
| HEADHUNTER GROUP PLC | 1 | Q1 2023 | 0.3% |
View University of Wisconsin Foundation's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
View University of Wisconsin Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.